4//SEC Filing
Dissanaike Sharmila 4
Accession 0001209191-22-062187
CIK 0000818033other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:20 PM ET
Size
7.2 KB
Accession
0001209191-22-062187
Insider Transaction Report
Form 4
Dissanaike Sharmila
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-12-16+77,160→ 77,160 totalExercise: $2.74Exp: 2032-12-16→ Common Stock (77,160 underlying) - Award
Common Stock
2022-12-16+38,580→ 55,282 total
Footnotes (2)
- [F1]The shares were granted as restricted stock units which vest in full on December 16, 2023.
- [F2]The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001885069
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:20 PM ET
- Size
- 7.2 KB